ABSTRACT
Introducción: la infección crónica del catéter involucra generalmente la colonización del manguito de dacrón (ôcuffõ) externo; sin su remoción el tratamiento antibiótico es inefectivo, la técnica de destechado de catéter ha sido descrita como una alternativa a la extracción del catéter peritoneal. Material y métodos: Se analizaron datos en forma retrospectiva de 13 pacientes. Se evaluó la evolución luego del destechado, considerando como fracaso del tratamiento a la aparición de nueva infección en el orificio, túnel o peritonitis asociada al mismo germen. Resultados: Entre los años 1997-2014, se le practicó destechado a 13 pacientes. Edad promedio 46,23 años (IC 95%: 35,92 años û 56,54 años). Sexo masculino 9, 69,23% (IC 95%: 41,95% û 96,50%).Gérmenes estafilococo 7, pseudomona 2, polimicrobiano 1, cultivo negativo 3. Hubo curación en 9 pacientes, 69,23% (IC 95%: 41,95% û 96,06) no hubo asociación estadística entre sexo, edad, resultado microbiológico, presencia de hemodiálisis previa, tipo de catéter, técnica quirúrgica ni con el cirujano que realizó el procedimiento (p> 0.05). Discusión: La extracción del catéter implica la transferencia transitoria a hemodiálisis y una nueva cirugía de recolocación, si bien existe poca experiencia con la técnica de destechado, puede ser una alternativa válida, permitiendo a un grupo de pacientes continuar con el tratamiento de DP. Conclusión: La cirugía de destechado ha resultado beneficiosa en el 69,23% de los casos (9 pacientes) independientemente del tipo de germen presente, representando un tratamiento aceptable que evita la remoción del catéter permitiendo así la continuidad de la modalidad, disminuyendo la necesidad de emplear terapias más agresivas.
Introduction: chronic catheter infection usually involves external Dacron cuff colonization, without its removal, antibiotic treatment proved ineffective. Catheter unroofing technique has been described as an alternative to peritoneal catheter removal. Material and methods: We analyzed the data from 13 patients retrospectively. Evolution after unroofing was evaluated, considering as treatment failure the appearance of new infection in the hole, tunnel or peritonitis associated to the same germ. Results: Between 1997-2014 years, unroofing was performed on 13 patients. Mean age-rate: 46.2 (IC 95%: 35.9 years û 56.5 years) male sex 9, 69.23%. Germs: staphylococcus 7, pseudomona 2, polymicrobial 1, negative culture 3. Nine patiens healed: 69.2%; there was no statistical association among sex, age, microbiological result, previous hemodialysis use, type of catheter, surgical technique or with the surgeon who performed the procedure (p> 0.05). Discussion: Catheter removal implies transient transference to hemodialysis and new replacement surgery, although there is few experience with this technique, it could be an acceptable alternative, enabling a group of patients to continue with PD treatment. Conclusion: Unroofing technique proved to be beneficial in 69.2% of the cases (9 patients) independently of the type of germ present, representing an acceptable treatment which avoids catheter removal, enabling the procedure to continue, and decreasing the need to employ more aggressive therapies.
Subject(s)
Male , Female , Humans , Catheterization , Infections , Peritoneal Dialysis/adverse effects , Renal Dialysis/instrumentationABSTRACT
Oxidative stress, resulting from the imbalance between reactive oxygen species (ROS) formation and antioxidant defenses, plays a major role in the pathogenesis of Parkinson's disease (PD). However, the contribution of levodopa (LD) therapy to oxidative damage is still debated. We investigated oxidative stress in peripheral blood mononuclear cells (PBMCs) from LD-treated PD patients and healthy subjects. Increased ROS production associated with unaltered glutathione reductase activity was detected in PBMC from PD patients. LD daily dosage appeared to be inversely correlated with ROS levels and positively associated with GR activity, suggesting a protective role for LD on PBMCs redox status. Our data support the view of systemic oxidative stress involvement in PD and give further rationale for using PBMCs as an easily accessible ex-vivo dopaminergic model for exploring the biological effects of LD therapy.
